-
Mashup Score: 0A Look at the Teneo Excimer Laser - 27 day(s) ago
I t’s been over a decade since a new general-purpose excimer laser was approved by the U.S. Food and Drug Administration. Earlier this year, the drought came to an end with the approval of the Teneo Excimer Laser Platform (Bausch + Lomb) in January. Here, we’ ll take a look at the new machine. The Technolas Teneo 317 Model 2 is indicated for myopia and myopic astigmatism LASIK, treating up to -10 D of myopic astigmatism, with sphere between -1 D and cylinder between zero and -3 D, according to the
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Maximizing Vision After Cataract Surgery - 28 day(s) ago
By Catlin Nalley, Contributing Editor W ith more than three million Americans undergoing cataract surgery each year, it is one of the most common — and safest — procedures performed in the United States. And ongoing advancements in surgical techniques and intraocular lens technology support the efforts of ophthalmologists who continuously strive to ensure their patients have the best possible visual outcomes. Maximizing outcomes depends on a number of factors and doesn’ t end with the removal of the
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0First-Line Treatment: SLT or Medication? - 1 month(s) ago
By Michelle Stephenson, Contributing Editor T r aditionally, glaucoma treatment has consisted of medication, then laser if needed, and then, if it were necessary, surgery. However, laser proponents say that, due to medication’s drawbacks — such as non-compliance — and the safety and efficacy of selective laser trabeculoplasty being demonstrated in recent studies, SLT should be considered the first-line treatment. Of course, this is an opinion not shared by all. Here, glaucoma specialists review the pros
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 9The Journey to True Accommodation - 1 month(s) ago
By Andrew Beers, Associate Editor T hough intraocular lenses have been around a long time, the market continues to grow and improve each year as new innovations are made. Patients who undergo cataract surgery are offered a host of IOLs for implantation, such as monofocal, multifocal and extended depth-of-focus lenses. But what if there was an IOL that could precisely mimic the human crystalline lens? Here, we take a look at several of the accommodative IOL concepts in development. There have been many
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Home - 1 month(s) ago
• Brief overview of the importance of evaporation in dry eye disease • Introduction to MIEBO – what it is, how it works • Review of pivotal efficacy and safety data • Case presentation(s) to identify appropriate evaporative dry eye disease patients APRIL 5, 2024 Registration: 7:15 PM ET Program: 7:30 PM – 8:30 PM ET Davio’s Seaport 26 Fan Pier Boulevard Boston MA, 02210 Laura Periman, MD Periman Eye Institue Seattle, WA Darrell White, MD Skyvision Centers Westlake, OH MIEBO ™ (perfluorohexyloctane ophthalmi
Source: na.eventscloud.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 5Review of Ophthalmology – Monthly Publication for Ophthalmologists - 1 month(s) ago
Review of Ophthalmology highlights current, clinically relevant information on surgical techniques, disease diagnosis and management and new technologies
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 10IOP Spikes in Glaucoma Subtypes After Phaco - 1 month(s) ago
R esearchers evaluated risk factors for intraocular pressure spikes in glaucomatous eyes following cataract surgery using the IRIS Registry, as part of a retrospective clinical cohort study. Adults with IRIS Registry data who underwent standalone phacoemulsification between January 1, 2013, and September 30, 2019, were included. An IOP spike was defined as a postoperative IOP > 30 mmHg and > 10 mmHg from baseline within the first postoperative week. Odds ratios for demographic and clinical characteristics
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 0Home - 1 month(s) ago
• Brief overview of the importance of evaporation in dry eye disease • Introduction to MIEBO – what it is, how it works • Review of pivotal efficacy and safety data • Case presentation(s) to identify appropriate evaporative dry eye disease patients APRIL 5, 2024 Registration: 7:15 PM ET Program: 7:30 PM – 8:30 PM ET Davio’s Seaport 26 Fan Pier Boulevard Boston MA, 02210 Laura Periman, MD Periman Eye Institue Seattle, WA Darrell White, MD Skyvision Centers Westlake, OH MIEBO ™ (perfluorohexyloctane ophthalmi
Source: na.eventscloud.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 10IOP Spikes in Glaucoma Subtypes After Phaco - 1 month(s) ago
R esearchers evaluated risk factors for intraocular pressure spikes in glaucomatous eyes following cataract surgery using the IRIS Registry, as part of a retrospective clinical cohort study. Adults with IRIS Registry data who underwent standalone phacoemulsification between January 1, 2013, and September 30, 2019, were included. An IOP spike was defined as a postoperative IOP > 30 mmHg and > 10 mmHg from baseline within the first postoperative week. Odds ratios for demographic and clinical characteristics
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 6Systemic Factors In Glaucoma - 2 month(s) ago
E levated intraocular pressure is usually considered the only modifiable risk factor for glaucoma, but particularly for normal-tension disease, where progression may continue despite pressures in the normal to low range, there may be systemic pa thogenic factors at play, some of which are potentially modifiable. Here, I’ ll discuss several of those less commonly considered systemic factors and what recommendations we can offer to our patients. The vascular hypothesis of glaucomatous optic neuropathy is
Source: www.reviewofophthalmology.comCategories: General Medicine News, OphthalmologyTweet
The new Teneo Excimer Laser is the first excimer laser to become FDA-approved in over a decade. It's indicated for myopia and myopic astigmatism LASIK, treating up to -10 D of myopic astigmatism, with sphere between -1 D and cylinder between 0 and -3 D. https://t.co/paoppQY9Jp https://t.co/dhat5pdj1Z